Upcoming Webinars

Advances in Ocular Melanoma

Wednesday, 22 April 2026 | 7:00 – 8:30 p.m. ET

This webinar provides a practical overview of ocular melanoma, including key concepts in diagnosis and treatment as cases become more frequently recognized in clinical practice. Faculty will review the management of uveal melanoma, with a focus on percutaneous hepatic perfusion (PHP), and discuss immunoembolization approaches for treating melanoma metastases to the liver.

Faculty

Robert Adamo, MD

Thomas Jefferson University

Shaheer Khan, DO

Northwell Health

Eric Wehrenberg-Klee, MD

Harvard University

Register Now

This webinar is sponsored by:

Thoracic Diseases: Learning from Our Own, Helping Others, and Knowing When to Walk Away

Wednesday, 29 April 2026 | 7:00 – 8:30 p.m. ET

This webinar examines real-world complications in thoracic interventional oncology, drawing practical lessons from lung ablation and patient management. Faculty will review strategies to prevent and manage complications related to lung biopsy and lung tumor ablation, including insights on what they would approach differently in hindsight. Attendees will also explore clinical scenarios where thoracic interventional oncology can help optimize outcomes for patients who are not ideal candidates for surgery or radiation therapy.

Faculty

Florian J. Fintlemann, MD

Harvard University

DaeHee Kim

Brown University

Robert Short, MD

Dayton VA Medical Center

Register Now

This webinar is sponsored by:

Missed a Session?

Catch up anytime — previous webinars in this series are available on our on-demand page.

View On-Demand Webinars

Targeting Tumors from Within: Intratumoral Therapies and Team-Based Care in Metastatic Melanoma

Postponed: Stay tuned for more details

Join us for an engaging webinar titled “Targeting Tumors from Within: Intratumoral Therapies and Team-Based Care in Metastatic Melanoma,” sponsored by Replimune and Johnson & Johnson. This session will explore the evolving treatment landscape for advanced melanoma, with a particular focus on patients who have progressed on PD-1 inhibitors. Attendees will gain valuable insights into second-line treatment strategies, including the role of oncolytic immunotherapies.

Faculty

Rahul Sheth, MD, FSIR

MD Anderson Cancer Center

Michael Wong, MD, PhD, FRCPC

Roswell Park Comprehensive Cancer Center

This webinar is sponsored by: